IL-1β plays a relevant role in the activation of various signaling pathways, including the NFκB transcription factor, which regulates the production and release of pro-inflammatory mediators essential for the development and progression of glioma [32]. The gene discussed is NFKB1; the disease is central nervous system cancer.